Advertisement
The cheap and widely available steroid dexamethasone reduced the risk for death among seriously ill COVID-19 patients by up to a third

Steroid May Reduce COVID-19 Death Risk by Up to One-Third

0
Dexamethasone appears promising for patients with severe illness
Nonpharmaceutical interventions have been beneficial for slowing COVID-19 growth on a global level and within Europe

Nonpharmaceutical Interventions Slow COVID-19 Growth

0
Interventions achieved beneficial outcomes in global study in six countries and in Europe-wide study
Approximately 12 percent of patients with severe acute respiratory syndrome coronavirus 2 infection report gastrointestinal symptoms

Gastrointestinal Symptoms Not Uncommon With COVID-19

0
Viral shedding in feces raises concerns for possible fecal-oral route of transmission
Clinical manifestations of COVID-19 in children differ widely from adult cases

Pediatric COVID-19 Symptoms Differ From Those Seen in Adults

0
Fever and respiratory symptoms common but not considered a hallmark of the disease in children
For patients with thoracic cancer

COVID-19 Death Rate High for Patients With Thoracic Cancer

0
Of those eligible for intensive care unit admission, only 10 percent admitted to ICU
With most state reopenings well underway

COVID-19 Cases Rising in Many States as Reopening Continues

0
25,000 complaints filed against businesses in Manhattan and elsewhere for violating reopening plan
Black Americans are much more likely than other Americans to say a relative or close friend has died of COVID-19

Black Americans Much More Likely to Have Lost Loved Ones to COVID-19

0
11 percent of black adults say someone close to them has died; rates are 5 percent among Americans overall
The American Red Cross will test all blood

Blood Donors Will Get Results of Coronavirus Antibody Test, Red Cross Says

0
Positive test result does not confirm immunity to the virus, and test is not meant to diagnose illness
The U.S. Food and Drug Administration has withdrawn its emergency authorization for the use of chloroquine phosphate and hydroxychloroquine sulfate in the fight against COVID-19.

FDA Pulls Emergency Approval of Hydroxychloroquine for COVID-19

0
Agency now says the drugs should not be used outside of clinical trials
Patients with type 2 diabetes who develop obstructive sleep apnea are at higher risk for cardiovascular disease and other diabetes-related complications

Sleep Apnea in Patients With T2DM Ups Risk for Comorbidities

0
Patients with T2DM and OSA diagnosis at higher risk for cardiovascular, microvascular complications